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Abstract
Background: Chondroit in/dermatan sulfate (CS/DS) rich in N-
acetylgalactosamine 4,6-bissulfate (GalNAc(4,6SO4)) residues is present as
decorin and/or biglycan in mouse liver, and GalNAc(4,6SO4) residues
disappeared completely in N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase
(GalNAc4S-6ST) knockout (KO) mice. The aim of this study was to investigate
whether CS/DS rich in GalNAc(4,6SO4) residues participate in the progression or
resolution of liver fibrosis.
Methods: Wild type (WT) and GalNAc4S-6ST KO mice were treated with CCl4
for 5 weeks. After discontinuation of CCl4 administration, histochemical and
biochemical changes and expression of genes related to matrix components were
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Results and conclusion: On 2 days after cessation of CCl4 administration, higher
fibrosis was observed in KO mice than in WT mice by Sirius Red staining. Serum
alanine aminotransferase activity was higher in KO mice than in WT mice.
Hydroxyproline contents and Sirius Red staining showed that repair of liver
fibrosis in the recovery stages appeared to be delayed in KO mice. Expression of
mRNA of matrix metalloproteinase (MMP)-2, MMP-13 and versican peaked at 2
days after cessation of CCl4 administration and was higher in KO mice than in WT
mice. Expression of MMP-9 in the recovery stage was lower in KO mice than in
WT mice. Our findings demonstrate that defect in GalNAc4S-6ST, which resulted
in disappearance of CS/DS containing GalNAc(4,6SO4), appear to contribute to
progression of liver fibrosis, delayed recovery from fibrosis, and various changes
in the expression of proteoglycans and MMPs in carbon tetrachloride–treated mice.
Keywords: Cell biology, Biochemistry
1. Introduction
N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase (GalNAc4S-6ST) transfers
sulfate to position 6 of GalNAc(4SO4) residues of chondroitin sulfate (CS)/
dermatan sulfate (DS) to form GalNAc(4,6SO4) residues. GalNAc4S-6ST and CS/
DS containing GalNAc(4,6SO4) residues (CS/DS-E) have been implicated in
various biological functions. CS/DS-E was reported to involve in the regulation of
neurite outgrowth [1, 2, 3, 4]. CS/DS-E was found to affect the growth and
metastatic property of cancer cells [5, 6, 7]. CS/DS-E enhanced differentiation of
osteoblast [8, 9], whereas CS/DS-E inhibited differentiation of osteoclast [10].
Downregulation of GalNAc4S-6ST improved left ventricular function and
ameliorated the progression of cardiac remodeling in chronic heart failure after
experimental autoimmune myocarditis [11]. CS/DS-E enhanced chondrogenic
differentiation of ATDC5 cells [12].
We have found previously that highly sulfated CS/DSs in which IdoA-GalNAc
(4,6SO4) units amount to nearly 40% of the repeating disaccharides are present in
the mouse liver as GAG chains of decorin and/or biglycan, and that IdoA-GalNAc
(4,6SO4) units in CS/DS disappeared completely in GalNAc4S-6ST knockout
(KO) mice [13]. Presence of CS/DS-E in the mammalian liver had been reported
previously [14, 15]. Decorin and decorin mRNA were reported to increase in the
liver fibrosis [16, 17, 18]. In decorin KO mice, liver fibrosis induced by
thioacetamide was enhanced and the tissue repair delayed [19]. It was reported that
the acute liver damage after CCl4 administration was more severe in EXTL2 KO
mice in which glycosaminoglycans were overproduced than in wild type mice [20].
In liver cirrhosis of Long–Evans Cinnamon Rats, it was reported that the
remarkable increase in the content of oversulfated CS/DS and the decrease in the
degree of oversulfation of the CS/DS were observed in the fibrous lesion compared
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with the nonfibrous lesion [21]. These observations suggest that the highly sulfated
CS/DS with GalNAc(4,6SO4) residues attached to decorin might contribute to
regulation of fibrosis in the liver. In this report, we compared liver fibrosis induced
by carbon tetrachloride between GalNAc4S-6ST KO mice and wild type mice, and
found that enhanced fibrosis and delayed recovery were observed in GalNAc4S-
6ST KO mice.
2. Materials and methods
2.1. Materials
Heparitinase I (Flavobacterium heparinum, EC 4.2.2.8), heparitinase II (F.
heparinum, no number assigned), heparinase (F. heparinum, EC 4.2.2.7),
chondroitinase ABC, chondroitinase ACII, unsaturated disaccharides kit for HS
(heparan sulfate) or CS were purchased from Seikagaku Corp (Tokyo, Japan).
Pronase and collagenase D were from Roche Applied Science (Germany).
Deoxyribonuclease I was from Sigma-Aldrich Japan (Tokyo, Japan). Anti-type I
collagen antibody was from Cosmo Bio Corp (Tokyo, Japan). Anti-decorin
monoclonal antibody (Anti dermatan sulfate proteoglycan mAb, clone 6-B-6) and
anti-versican monoclonal antibody (Anti large proteoglycan mAb clone 2-B-1)
were from Seikagaku Corp (Tokyo, Japan). AlexaFluor546 conjugated anti-rabbit
IgG antibody was from Thermo Fisher Scientific (Yokohama, Japan). Histofine
(mouse staining kit) for mouse monoclonal antibody to mouse tissue was from
Nichirei (Tokyo, Japan). Envision kit/HRP (DAB) was from DAKO Japan (Tokyo,
Japan). Recombinant human TGF-β1 and recombinant murine TNF-α were
purchased from PeproTeck (NJ, USA)
2.2. Animals and administration of CCl4
GalNAc4S-6ST-knockout mice were generated as described previously [13]. Mice
used in the CCl4-induced fibrosis study had been back-crossed to BALB/c mice for
more than 10 generations. Mice used for preparation of hepatic stellate cell (HSC)
had been back-crossed to C57BL/6 N mice for more than 10 generations. Mice
were maintained in 12-hour light/12-hour dark cycles with free access to food and
water in a pathogen-free room at the Laboratory Animal Research Center, Aichi
Medical University. Mice (7-to-8-week-old females) were injected intraperitoneal-
ly with carbon tetrachloride (CCl4), which was diluted 2:5 in mineral oil (Sigma) at
a dose of 2.0 ml/kg (as CCl4) of body weight twice a week for a total of 9
injections. Control mice were injected with mineral oil alone. Number of mice used
for analysis was indicated under the legend of each figure. Mice were killed 2 days,
3 weeks, 6 weeks or 9 weeks after the last CCl4 injection, and blood and liver
samples were obtained. The liver was either fixed with 10% formaldehyde neutral
buffer solution (Nakalai Tesque, Kyoto, Japan) for histological examination or
Article No~e00138
3 http://dx.doi.org/10.1016/j.heliyon.2016.e00138
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
used for extraction of RNA, analysis of glycosaminoglycans and measurement of
the content of hydroxyproline. All animal procedures were approved by Animal
Research Committee of Aichi Medical University.
2.3. Determination of hydroxyproline
Hydroxyproline was determined by the method of Kivirikko et al. [22] as modified
by Nagatani et al. [23] after hydrolysis with 6 M HCl at 110 °C for 24 h. In this
modified method, reaction with chloramine T was carried out at 0 °C for 2 h.
2.4. Assay of alanine aminotransferase (ALT) activity
ALT activity was measured by using an ALT activity assay kit (BioVision)
according to the manufacturer’s protocol. To the reaction mixture, 3 μl of the
serum was added, and fluorescence (Ex/Em = 535 nm/587 nm) was determined at
20 min and 50 min.
2.5. Isolation of total RNA and determination of expression
levels of mRNAs by quantitative reverse-transcription polymer-
ase chain reaction (qRT-PCR)
Total RNA was isolated from mouse livers using Trizol (Invitrogen) or isolated
from the cultured HSCs using NucleoSpin XS (Macherey-Nagel). A reverse-
transcription reaction was performed using the High-capacity cDNA Archive kit
(Applied Biosystems, Foster City, CA). Quantitative RT-PCR was performed
using commercial specific primer pairs (for decorin, biglycan, versican, collagen
(COL)1a1, metalloproteinase (MMP)-2, MMP-9, MMP-13, tissue inhibitor of
metalloproteinase (TIMP)-1 and TIMP-2) and SYBR premix Ex TaqII (Takara,
Shiga, Japan). Normalization of each transcript was performed using β-actin
specific primer pairs (Takara, Shiga, Japan). The PCR products were analyzed in
real-time using ABI Prism 7000 system. Two independent experiments were
performed in triplicate to obtain the values.
2.6. Histological analysis and immunohistochemistry of liver
Tissues were fixed with 10% formaldehyde and embedded in paraffin according to
standard histological procedures and cut to 4 μm of sections. Collagen fiber was
stained with Sirius Red following nuclear-staining with hematoxylin. Images were
captured using a KEYEENCE BZ-9000 microscope. The area stained with Sirius
Red was measured using NIH ImageJ64. Briefly, each color picture was split into
Red, Green and Blue pictures. Using Green pictures, ratios of areas above a defined
threshold to total area were determined. For collagen type I immunostaining, the
sections were deparaffinized and then digested with 200 μl per section of
chondroitinase ABC (10 mU/ml) at room temperature for 30 min. After blocking
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with 1% BSA, the sections were incubated with anti-collagen type I antibody as the
first antibody at 4 °C overnight. After washing, sections were stained with
AlexaFluor546-conjugated anti-rabbit IgG antibody. The nuclei were stained with
DAPI. The immunohistochemistry of decorin and versican was carried out
according to the following steps: digestion with chondroitinase ABC, incubation
with anti-decorin antibody or anti-versican antibody, incubation with peroxidase-
conjugated anti-mouse IgG (mouse stain kit), and reaction with DAB.
2.7. Isolation of glycosaminoglycans from liver and its structural
analysis
The liver (about 400 mg) was homogenized in acetone and the acetone-insoluble
materials were dried. The dried materials were suspended in 2 ml 0.5 M NaOH and
stirred for 16 h at room temperature. After neutralization with 3 M acetic acid,
Actinase (0.5 mg/ml) and Tris-HCl, pH 8.0 (final 20 mM) were added and
incubated at 37 °C for 24 h. After heating at 100 °C for 5 min, the samples were
centrifuged at 10000 x g for 10 min. To the resulting supernatant fractions were
added 3 volumes of ethanol containing 1.3% potassium acetate, and glycosami-
noglycans were precipitated by centrifugation at 10000 x g for 10 min. The
precipitates were dissolved in 1 ml 20 mM Tris-HCl, pH 7.4 containing 20 mM
MgCl2, DNase I (0.1 mg/ml) and RNase A (0.1 mg/ml), and incubated for 2 h at
37 °C. After heating at 100 °C for 2 min, the samples were centrifuged at 10000 x g
for 10 min. From the resulting supernatant fractions, glycosaminoglycans were
recovered by ethanol precipitation as above, dissolved in 1 ml 20 mM Tris-HCl,
pH 7.2 containing 0.2 M NaCl and loaded onto a DEAE-Sephacel column (bed
volume 0.8 ml) equilibrated with the same buffer. The column was washed with 10
column volumes of 20 mM Tris-HCl, pH 7.2 containing 0.2 M NaCl and then
eluted with 3 column volumes of Tris-HCl, pH 7.2 containing 2 M NaCl. From the
eluates, glycosaminoglycans were recovered by ethanol precipitation as above. The
purified glycosaminoglycans were dissolved in 100 μl 50 mM sodium acetate
buffer, pH 5.0 containing 1.0 TRU Streptomyces hyaluronidase, and digested for
2 h at 37 °C. After digestion, 2 volumes of ethanol containing 1.3% potassium
acetate were added and the mixtures were left at −80 °C for 30 min.
Glycosaminoglycans were precipitated by centrifugation at 10000 x g for 30 min
at 4 °C. For disaccharide composition analysis of CS/DS, the purified
glycosaminoglycans were digested with a mixture of 30 munits chondroitinase
ABC and 30 munits chondroitinase ACII in 25 μl of 50 mM Tris-acetate buffer, pH
7.5, 0.1 mg/ml of bovine serum albumin for 4 h at 37 °C. For disaccharide
composition analysis of HS/heparin, the purified glycosaminoglycans were
digested with a mixture of 0.2 mU of heparitinase I, 0.1 mU of heparitinase II
and 0.2 mU of heparinase in 50 μl of 50 mM Tris-HCl buffer, pH7.2, 1 mM CaCl2
and 5 μg bovine serum albumin for 2 h at 37 °C. After filtration of the digests with
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Ultrafree-MC (5 kDa molecular weight cutoff filter: Millipore Corp.), the
unsaturated disaccharide products in the filtrates were analyzed by reverse-phase
ion-pair chromatography using Senshu Pak column Docosil with a fluorescence
detector according to Toyoda’s method [24] with slightly modified elution
conditions.
2.8. Isolation of hepatic stellate cells from wild type- and KO-
mouse liver
Hepatic stellate cells from the mouse liver were prepared according to the method
of Machmeyer et al. [25] with a slight modification. Briefly, livers were perfused
successively with PBS containing 0.09% glucose, 0.5 mM EGTA and 0.0006%
phenol red for 5 min, DMEM/F12 containing 0.4 mg/ml of pronase E for 5 min and
DMEM/F12 containing 0.4 mg/ml of collagenase D for 8 min at a flow rate of
5 ml/min. Dissected livers were placed in 10 ml of DMEM, cut into small pieces,
and filtrated through 70-μm cell strainer. The cell strainer was washed once with
5 ml DMEM containing DNase I. The pooled filtrate was centrifuged at 50 x g for
2 min. After the supernatant was moved to a new tube, pellet was suspended in
5 ml of DMEM and centrifuged again. Both the supernatants were pooled and
centrifuged at 700 x g for 10 min. The cell pellet was suspended in 10 ml 9% (w/v)
HistoDenz (Sigma-Aldrich). After loading 1.5 ml of DMEM on the top of the
suspension, the cell suspension was centrifuged at 1400 x g for 17 min. HSCs were
recovered from the interface between HistoDenz and top layer, and plated in
DMEM containing 10% FBS. Two hours after plating, the culture medium
containing unattached cells was replaced with fresh medium. More than 90% of the
cells thus obtained showed starlike morphology with a lot of lipid droplets, which
are characteristic of HSCs.
2.9. Effects of TGF-β1 and TNF-α on the expression of mRNAs
in the cultured Hepatic stellate cells (HSCs) obtained from wild
type- and KO-mouse liver
HSCs cultured for 6 days were seeded in 24-well plates at 1 × 104 cells/well. Two
days after seeding, the wells were washed with DMEM once and DMEM
containing 0.4% FBS (medium A) was added to each well. After incubation for
24 h, the medium was replaced with fresh medium A containing TGF-β1 (10 ng/
ml) or TNF-α (10 ng/ml) and incubation was continued for further 8 h. The cells
were harvested and total RNA was prepared. Expression of the mRNAs of COL1a1
and MMP-13 were analyzed.
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2.10. Gelatin-substrate zymography
Frozen livers were homogenized by a polytron homogenizer in 10-fold extraction
buffer (50 mM Tris-HCl, pH 7.5, 0.15 M NaCl, 0.02%Triton X-100) for 30 sec,
and the homogenates were then shaken for 30 min at 4 °C. The homogenates were
centrifuged at 12,000 rpm for 15 min. The protein concentration of the
supernatants was determined by DC Protein Assay kit (Bio-Rad). Aliquots (30
μg of protein) of each sample were separated in 7.5% SDS-polyacrylamide gel
containing 1 mg/ml gelatin. After electrophoresis, the gels were washed with 2.5%
Triton X-100 for 30 min, and then shaken in a development solution (50 mM Tris-
HCl pH 7.5, 5 mM CaCl2, 0.2 M MgCl2) at 70 rpm for 30 min. The gels were
incubated in the fresh development solution at 37 °C for 6 h. After incubation, the
gels were stained with 0.5% (w/v) CBBR-250 for 1 h, and then destained with a
solution (50% methanol, 10% acetic acid, 40% H2O). The gelatinase activity was
determined by measurement of the intensity of the transparent bands using NIH
Image software.
2.11. Statistical analysis
Comparisons between groups were assessed by Student’s t test. Values of p < 0.05
were considered to be statistically significant.
3. Results
3.1. Deficient in GalNAc4S-6ST results in advanced fibrosis and
delayed recovery from fibrosis
Mice were injected intraperitoneally with carbon tetrachloride (CCl4) twice a week
for a total of 9 injections as described under “Experimental Procedures”. Control
mice were injected with mineral oil alone. Sirius Red staining showed more
advanced liver fibrosis and delayed recovery in GalNAc4S-6ST KO mice than in
wild type mice (Fig. 1A). Before injection of CCl4, Sirius Red hardly stained livers
from both wild type and GalNAc4S-6ST KO mice. On 2 days after the last CCl4
injection, Sirius Red clearly stained portal tracts and boundary of hepatic lobule,
but hardly stained peripheral regions of the central veins. On 3 weeks and
thereafter, the stain faded gradually. On 2 days, 6 weeks and 9 weeks after the last
CCl4 injection, relative fibrosis obtained from Sirius Red staining was significantly
higher in GalNAc4S-6ST KO mice than in wild type mice (Fig. 1B). Hydoxypro-
line contents in the liver of wild type and GalNAc4S-6ST KO mice were
determined 2 days, 3 weeks, 6 weeks and 9 weeks after the last CCl4 injection
(Fig. 2). The amounts of hydroxyproline increased up to 3 weeks in wild type mice
and decreased thereafter, whereas they reached a plateau on 3 weeks in GalNAc4S-
6ST KO mice. As a result, the hydroxyproline contents were significantly higher in
GalNAc4S-6ST KO mice than in wild type mice on 6 weeks and 9 weeks after the
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last CCl4 injection. These observations also suggest that defect in CS/DS-E may
result in delayed recovery from fibrosis.
3.2. Liver damage induced by CCl4 administration was more
severe in KO mice than in WT mice
It is well known that activity of serum alanine aminotransferase (ALT) increases
on liver injury. We determined whether the activity of the enzyme induced by the
administration of CCl4 might be affected by deficient in GalNAc4S-6ST (Fig. 3).
[(Fig._1)TD$FIG]
Fig. 1. Sirius Red staining and detection of COL1 by immunostaining of the livers from wild type mice
(WT) and GalNAc4S-6ST KO mice (KO). (A) Sirius Red staining. Magnified pictures of regions
surrounded by rectangles in 2D are shown in 2D-M. Portal tracts, boundaries of hepatic lobule and
central veins are indicated by filled arrowheads, open arrowheads and arrows, respectively in 2D-M.
Bar: 100 μm. (B) Relative fibrosis determined from the Sirius Red staining. The histograms show the
ratios (percentage) of areas above a defined threshold to total areas from wild type (filled bar) and KO
mice (open bar). Values indicate averages of data obtained from three mouse livers. Five different
pictures were measured per each mouse. SDs of data are indicated above each bar. *p < 0.01, **p <
0.05. (C) Immunostaining of COL1 by anti-COL1 antibody. Bar: 100 μm.
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At 24 h after the last CCl4 injection, ALT activities were elevated markedly, and on
three week and thereafter these activities were decreased to the control level; the
activity at 24 h was significantly higher in GalNAc4S-6ST KO mice than in wild
type mice (Fig. 3B). These results suggest that defect in GalNAc4S-6ST, which
resulted in the disappearance of CS/DS-E, may make the liver more susceptible to
the harmful effects of CCl4.
3.3. Defect in GalNAc4S-6ST affected expression of type I
collagen, decorin and versican
In Fig. 1C, immunostainings of Type I collagen are shown. On 2 days after the last
CCl4 injection, Type I collagen was found in portal tracts and boundary of hepatic
[(Fig._2)TD$FIG]
Fig. 2. Determination of hydroxyproline in the livers obtained from wild type mice and GalNAc4S-6ST
KO mice. The histograms show the hydroxyproline contents of the livers from wild type (filled bar) and
KO mice (open bar). Number of mice used for experiments was 3, 5, 7, 8, and 9 for control, 2 days, 3
weeks, 6 weeks and 9 weeks, respectively. Values indicate averages of data obtained from these mice,
and SDs of data are indicated above each bar. *p < 0.01, **p < 0.03.
[(Fig._3)TD$FIG]
Fig. 3. Determination of activities of alanine aminotransferase in the serum obtained from wild type
mice and GalNAc4S-6ST KO mice. Mice were treated as described under “Materials and methods” and
serum samples of control and CCl4-treated mice were obtained. The histograms show the activity of
wild type (filled bar) and KO mice (open bar) (*p < 0.03). Values indicate averages of 3 mice, and SDs
of data are indicated above each bar.
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lobules, and was weakly found in sinusoids in wild type mouse liver. In
GalNAc4S-6ST KO mouse liver, Type I collagen was detected in essentially the
same regions as wild type mouse liver, but sinusoids were stained very weakly. On
3 weeks, the stained areas spread to the periphery of hepatocytes and sinusoids in
wild type mouse liver, while most of Type I collagen still remained on portal tracts
and boundary of hepatic lobules in GalNAc4S-6ST KO mouse liver. On 6 weeks,
Type I collagen was detected only weakly in the portal tracts, boundary of hepatic
lobules and sinusoids in both wild type and GalNAc4S-6ST KO mouse liver.
To determine if the deficiency in GalNAc4S-6ST may influence the expression of
decorin under administration of CCl4, we stained the livers by anti-decorin
antibody (Fig. 4A). On 2 days after cessation of CCl4 injection, decorin was found
at the boundary of hepatic lobules and portal tracts but not at the periphery of
central veins in the livers of both wild type and GalNAc4S-6ST KO mice. On 6
weeks after the last CCl4 injection, sinusoids became positive; the positive areas on
the sinusoids in wild type mouse liver were much clearer than those in GalNAc4S-
6ST KO mouse liver. In contrast, decorin detected in the boundary of hepatic
[(Fig._4)TD$FIG]
Fig. 4. Detection of decorin and versican in the livers obtained from wild type mice (WT) and
GalNAc4S-6ST KO mice (KO). Magnified pictures of regions surrounded by rectangles in 6W in (A)
and 2D in (B) are shown in 6W-M and 2D-M, respectively. Portal tracts, boundaries of hepatic lobule
and sinusoids are indicated by filled arrowheads, open arrowheads and arrows, respectively in 6W-M
and 2D-M. The results show representative photographs. (A) Immunostaining of decorin with anti-
decorin antibody. (B) Immunostaining of versican with anti-versican. Bar: 100 μm.
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lobules and portal tracts appeared sharper in GalNAc4S-6ST KO mouse liver than
in wild type mouse liver. On 9 weeks after the last CCl4 injection, portal tracts in
GalNAc4S-6ST KO mouse liver still remained positive, whereas most of the
positive areas disappeared in wild type mouse liver.
Versican, another extracellular matrix proteoglycan containing CS/DS, was
detected in portal tracts, sinusoids and periphery of central vein of the liver 2
days after the last CCl4 injection in both wild type and GalNAc4S-6ST KO mouse
livers (Fig. 4B). The expression of versican in GalNAc4S-6ST KO mouse liver
appeared to be higher than that in wild type mouse liver. On 3 weeks and
thereafter, versican was hardly detected in both wild type and GalNAc4S-6ST KO
mouse livers. The observation that versican was detected in sinusoids and
periphery of central vein on 2 days after the last CCl4 injection contrasted
markedly with the observation that decorin was nearly undetectable in these
regions on the same day.
3.4. Expression of mRNA of versican was quite different from
those of decorin and biglycan in fibrosis
As shown in Fig. 4, expression of core proteins of decorin and versican was clearly
different from each other. To confirm whether such difference may reflect
expression patterns of mRNAs of these proteoglycans, we determined expression
of mRNAs of decorin and versican (Fig. 5). Expression of biglycan was also
determined because liver biglycan was found to bear highly sulfated CS/DS-E [13].
The levels of mRNA of both decorin and biglycan were increased moderately after
cessation of CCl4 injection; however there were no significant difference between
wild type mice and GalNAc4S-6ST KO mice. In contrast, expression of mRNA of
versican increased markedly on 2 days after the last CCl4 injection and dropped to
the control level on 3 weeks; the expression level on 2 days was significantly
higher in GalNAc4S-6ST KO mice than in wild type mice. Such expression
patterns of mRNA of decorin and versican coincide well with the immunohisto-
chemical detection of these core proteins indicated in Fig. 4.
3.5. Expression of mRNAs of sulfotransferases involved in the
synthesis of CS/DS-E and HS/heparin in fibrosis
C4ST-1 and GalNAc4S-6ST are involved in the synthesis of CS/DS-E. We
determined expression of these sulfotransferases in the liver fibrosis. We also
determined expression of HS6ST-1 and HS6ST-2, which are involved in the
synthesis of HS/heparin (Fig. 5). The level of mRNA of C4ST-1 and GalNAc4S-
6ST showed a peak on 2 days and 3 weeks, respectively, after cessation of CCl4
injection. Expression of HS6ST-2 was increased ten times as large as that of
control on 2 days, whereas expression of HS6ST-1 hardly changed during fibrosis.
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No significant differences in the expression of C4ST-1, HS6ST-1 and HS6ST-2
were observed between wild type and GalNAc4S-6ST KO mice.
3.6. Change in total amounts and disaccharide composition of
CS/DS and HS/heparin on the administration of CCl4
To determine if administration of CCl4 may affect amounts and composition of
glycosaminoglycans, we measured total amounts and disaccharide composition of
CS/DS and HS/heparin obtained from the liver (Fig. 6). After the last CCl4
injection, the amounts of CS/DS were significantly increased in both wild type and
GalNAc4S-6ST KO mice. A significant difference between wild type and
GalNAc4S-6ST KO mice was obtained on 9 weeks. As reported previously, GlcA/
IdoA (UA)-GalNAc(4,6-bissulfate) (GalNAc4S6S) unit disappeared completely
[(Fig._5)TD$FIG]
Fig. 5. Expression of mRNAs of proteoglycans and sulfotransferases in the livers obtained from wild
type mice and GalNAc4S-6ST KO mice. The histograms show the relative expression of the mRNAs of
decorin, biglycan, versican (*p < 0.05), C4ST-1, GalNAc4S-6ST, HS6ST-1, and HS6ST-2 in the livers
from wild type (filled bar) and KO mice (open bar). Values indicate averages of 3 mice or more, and
SDs of data are indicated above each bar.
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and instead UA-GalNAc(4-sulfate) (GalNAc4S) unit was increased in GalNAc4S-
6ST KO mice. In wild type mice, UA-GalNAc4S6S unit was decreased on 2 days
after the last CCl4 injection, and recovered to the control level on 3 weeks and
thereafter. Differences in the proportions of UA-GalNAc6S and GlcA/IdoA (2-
sulfate) (UA2S)-GalNAc4S between wild type mice and GalNAc4S-6ST KO mice
were also significant at all time points; however, reasons for these differences
remain obscure. The total amount and disaccharide composition of heparan sulfate
in the liver varied only slightly on the administration of CCl4; nevertheless,
[(Fig._6)TD$FIG]
Fig. 6. Total amounts and disaccharide compositions of CS/DS obtained from the livers of wild type
mice and GalNAc4S-6ST KO mice. The histograms show the total amount (*p < 0.05) of CS/DS, and
percentage compositions of unsaturated disaccharide derived from UA-GalNAc, UA-GalNAc4S (*p <
0.0005), UA-GalNAc6S (*p < 0.05, **p < 0.005), UA-GalNAc4S6S (*p < 0.0001), UA2S-GalNAc4S
(*p < 0.005, **p < 0.00001), and UA2S-GalNAc4S6S in the CS/DS of wild type (filled bar) and KO
mice (open bar). Values indicate averages of 3 mice, and SDs of data are indicated above each bar.
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proportion of UA2S-GlcNS6S was significantly lower in GalNAc4S-6ST KO mice
than in wild type mice (data not shown).
3.7. Effects of defect in GalNAc4S-6ST on the expression of
mRNAs involved in the synthesis and degradation of collagens
As indicated in Fig. 1 and Fig. 2, defect in GalNAc4S-6ST appeared to promote
liver fibrosis and to delay recovery from fibrosis in CCl4-treated mice. From these
observations, it may be rational to postulate that the rate of synthesis and/or
degradation of collagen might be affected in GalNAc4S-6ST KO mice. To confirm
such possibilities, we determined expression of mRNAs of α-smooth muscle actin
[(Fig._7)TD$FIG]
Fig. 7. Expression of mRNAs of MMPs and TIMPs in the livers obtained from wild type mice and
GalNAc4S-6ST KO mice. The histograms show the relative expression of the mRNAs of COL1a1,
MMP-2 (*p < 0.001), MMP-9 (*p < 0.05, **p < 0.01), MMP-13 (*p < 0.01), TIMP-1, TIMP-2 and
α-SMA in the livers from wild type (filled bar) and KO mice (open bar). Values indicate averages of 3
mice except for the expression of TIMP-2 in KO mice on 2 days in which one sample was available.
SDs of data are indicated above each bar.
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(α-SMA), COL1a1, MMPs and TIMPs (Fig. 7). The expression of α-SMA that is
thought to reflect activation of HSCs peaked on 2 days after the last CCl4 injection,
but there were no significant differences in the expression of α-SMA between wild
type mice and GalNAc4S-6ST KO mice. The expression of COL1a1 on 2 days
after the last CCl4 injection was ten times as large as that of control, and decreased
precipitously. There were no significant differences in the expression of COL1a1
between wild type mice and GalNAc4S-6ST KO mice at any time points,
suggesting that the rate of synthesis of Type I collagen should not be affected by
the defect in GalNAc4S-6ST. Expression of MMPs showed species-specific
pattern. Expression of MMP-2 and MMP-13 peaked on 2 day after cessation of
CCl4 injection and decreased thereafter. On 2 days after the last CCl4 injection,
expression of these MMPs of was significantly higher in GalNAc4S-6ST KO mice
than in wild type mice. Expression of MMP-13 returned to the control level on 6
weeks, whereas expression of MMP-2 still showed an elevated level on 9 weeks.
Unlike MMP-13 and MMP-2, expression of MMP-9 in wild type mice peaked on 3
weeks after the last CCl4 injection, whereas, expression of MMP-9 in GalNAc4S-
6ST KO mice did not show clear peak on 3 weeks and was significantly lower than
that in wild type mice (Fig. 7). Expression pattern of TIMP-1 was similar to that of
MMP-13. Expression of TIMP-2 was increased moderately on 2 days to 3 weeks.
No significant differences in the expression of TIMP-1 and TIMP-2 were found
between wild type mice and GalNAc4S-6ST KO mice at any time points.
3.8. Liver MMP-9 activity was lower in GalNAc4S-6ST KO mice
than in wild type mice
As shown in Fig. 7, expression of MMP-9 mRNA was significantly lower in
GalNAc4S-6ST KO mice than in wild type mice. To confirm that MMP-9 activity
was also decreased in GalNAc4S-6ST KO mice, we determined MMP-9 activity
included in the extracts from the livers by using zymography. In Fig. 8A,
representative results are shown. A band detected at 105 kDa and a weak band at
68 kDa are thought to correspond to proMMP-9 and MMP-2, respectively. The
densities of 105 kDa bands were quantitated by NIH ImageJ64 and expressed in
Fig. 8B. The activities of MMP-9 on 3 weeks after the last CCl4 injection were
more than 3 times higher than those of the controls in both wild type mice and
GalNAc4S-6ST KO mice. On 3 weeks and 6 weeks, the activities of MMP-9 were
significantly lower in GalNAc4S-6ST KO mice than in wild type mice. These
observations appeared to indicate that upregulation of MMP-9 in the CCl4-induced
liver fibrosis was hampered in GalNAc4S-6ST KO mice.
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3.9. Defect in GalNAc4S-6ST had little effect on the expression
of mRNAs of COL1a1 and MMP-13 in the cultured hepatic
stellate cells
As shown in Fig. 7, expression of MMP-2 and MMP-13 mRNA showed a peak on
2 days after the last CCl4 injection, and expression of these MMPs was
significantly higher in GalNAc4S-6ST KO mice than that in wild type mice. On the
other hand, expression of α-SMA mRNA also showed a peak on 2 days after the
last CCl4 injection. α-SMA is known to be a marker of the activated HSC,
suggesting that expression of these MMP genes may be due partly to activated
HSCs. To examine a possibility that defect in GalNAc4S-6ST may affect the gene
expression in HSC, we prepared HSCs from mouse liver and determined
expression of mRNAs of COL1a1 and MMP-13 under stimulation with TGF-β1
or TNF-α. As shown in Fig. 9, expression of COL1a1 was increased with TGF-β1
and expression of MMP-13 was increased with TNF-α. However, no significant
differences in the expression of these genes in HSCs were observed between wild
[(Fig._8)TD$FIG]
Fig. 8. Zymography of liver extracts obtained from wild type mice and GalNAc4S-6ST KO mice. (A)
Representative photographs of zymography of wild type (W) and KO (K) mice. Bands corresponding to
proMMP-9 and MMP-2 are indicated by arrows. (B) The histograms show the relative values of MMP-
9 (*p < 0.05, **p < 0.03) from wild type (filled bar) and KO mice (open bar). Values indicate averages
of 3 mice, and SDs of data are indicated above each bar.
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type mice and GalNAc4S-6ST KO mice. From these observations, it appears to be
unlikely that defect in GalNAc4S-6ST affects the gene expression in HSC.
4. Discussion
In CCl4-induced liver fibrosis, enhanced fibrosis and delayed recovery from
fibrosis were observed in GalNAc4S-6ST KO mice (Fig. 1 and Fig. 2). On 3 weeks
after the last injection of CCl4 and thereafter, expression of mRNA of MMP-9 and
MMP-9 activity were both lower in GalNAc4S-6ST KO mice than in wild type
mice. On the other hand, in thioacetamide-induced liver fibrosis, liver fibrosis was
enhanced and the tissue repair delayed in decorin KO mice, and MMP-9 activity
was lower in decorin KO mice [19]. Considering these overlapped observations, it
might be possible that CS/DS-E attached to decorin may bear some part of
functions of decorin proteoglycan in liver fibrosis. Decorin binds to TGF-β1 and
interfere with TGF-β1 activity [26]. Decorin inhibits proliferation of macrophages
and protects macrophages from the induction of apoptosis, and the effects of
decorin on macrophage activation were mediated through abolishing the binding of
TGF-β to macrophages [27]. TGF-β is a heparin-binding protein [28]. Since CS/
DS-E is a highly sulfated glycosaminoglycan similar to heparin, it might be
possible that CS/DS-E attached to decorin could bind TGF-β and modify the
activity of decorin toward TGF-β.
As shown in Fig. 7, expression of MMP-13 and MMP-2 mRNA peaked on 2 days
after cessation of CCl4 administration and the expression degree of these MMP
mRNAs was higher in GalNAc4S-6ST KO mice than in wild type mice. Elevation
[(Fig._9)TD$FIG]
Fig. 9. Expression of mRNAs of COL1a1 and MMP-13 in the hepatic stellate cells (HSCs) obtained
from the livers of wild type mice and GalNAc4S-6ST KO mice. The histograms show the relative
expression of the mRNAs of COL1a1 and MMP-13 of wild type (filled bar) and KO cells (open bar).
Values indicate averages of 3 or more than 3 mice, and SDs of data are indicated above each bar.
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of MMP-13 and MMP-2 mRNA might reflect the activation of fibrolysis.
Alternatively, elevation of these mRNA might be accompanied with acute liver
injury because MMP-13 was reported to express in CCl4-induced acute liver injury
[29], and because expression of MMP-2 was reported to increase in the aggressive
phase of liver fibrosis but decrease in the repair stage [30, 31]. From the results of
serum ALT activity, the livers on 2 days after cessation of CCl4 administration are
thought to be in acute phase of liver injury. The activity of serum ALT at 24 h and
expression of MMP-13 and MMP-2 mRNA on 2 days after cessation of CCl4
administration are both higher in GalNAc4S-6ST KO mice than in wild type mice,
suggesting that defect in GalNAc4S-6ST may make the liver more susceptible to
the CCl4-induced liver injury. The reasons why expression of MMP-2 and MMP-
13 was higher in GalNAc4S-6ST KO mice than in wild type mice remain obscure.
It is well known that activation of hepatic stellate cells (HSCs) plays important
roles in liver fibrosis [32]. Activation of HSC might be different between
GalNAc4S-6ST KO mice and wild type mice, and consequently expression of
MMP-13 and MMP-2 mRNA on 2 days after cessation of CCl4 administration
might become different between GalNAc4S-6ST KO mice and wild type mice [33,
34, 35]. However, this possibility seems to be unlikely because there were no
significant differences in the expression of COL1a1 and MMP-13 genes under
stimulation with TGF-β1 or TNF-α between wild type mice and GalNAc4S-6ST
KO mice as shown in Fig. 9. MMP-13 was reported to express in scar-associated
macrophages in the liver [36]. It remains to be studied whether expression of
MMP-13 in scar-associated macrophages might be affected by the defect of
GalNAc4S-6ST.
As shown in Fig. 7 and Fig. 8, expression of MMP-9 showed a peak during the
resolution stage and was lower in GalNAc4S-6ST KO mice than in wild type mice.
In this report it was not clarified why expression of MMP-9 was lower in
GalNAc4S-6ST KO mice than in wild type mice. MMP-9 was shown to express in
macrophages [37, 38] and dendritic cells [39], and to contribute to the repair from
fibrosis [39]. Because CS/DS-E has been found to express in macrophages derived
from monocytes [40], it might be possible that defect in GalNAc4S-6ST results in
disappearance of CS/DS-E present in macrophage, and influences expression of
MMP-9 in macrophages or dendritic cells through unidentified mechanism.
In wild type mice, UA-GalNAc4S6S unit was decreased on 2 days after the last
CCl4 injection, and recovered to the control level on 3 weeks and thereafter
(Fig. 6). These changes in the proportion of UA-GalNAc4S6S unit in CS/DS may
reflect the observation that expression of versican was increased 2 days after the
last CCl4 injection (Fig. 4B). Augmented expression of versican in the CCl4-
induced liver fibrosis has been observed [41]. Versican was thought to contain
minimal amount of highly sulfated CS/DSs because versican core protein could not
be identified in mouse liver proteoglycans containing highly sulfated CS/DS [13].
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If CS/DS-E favors the recovery from fibrosis as shown in Fig. 1 and Fig. 2,
expression of C4ST-1 and GalNAc4S-6ST that are both involved in the synthesis
of CS/DS-E should be increased when liver fibrosis proceeded. The observation
that expression of these sulfotransferases actually increased after the administration
of CCl4 (Fig. 5) seem to support the idea that CS/DS-E may play a certain role in
the recovery process. Expression of HS6ST-2 was markedly increased on 2 days
but expression of HS6ST-1 was not, suggesting that heparin-containing mast cells
may be increased in the acute stage, because HS6ST-2 but not HS6ST-1 was
shown to be involved mainly in the synthesis of highly sulfated heparin [42].
Localization of decorin and versican in the liver on 2 days after cessation of CCl4
administration was quite different from each other; decorin was rarely present on
the periphery of the central vein and sinusoids, but versican was clearly detected in
these regions. Expression of mRNA of decorin and versican was also much
different from each other; expression of decorin was increased moderately after
cessation of CCl4 injection, whereas expression of versican was markedly
increased 2 days after the last CCl4 injection. It is reported that the expression
of versican gene was higher in M1 macrophages than that in M2 macrophages [43,
44]. The increased expression of versican on 2 days after the last CCl4 injection
might reflect the polarization of macrophages.
Complete disappearance of UA-GalNAc4S6S disaccharides in GalNAc4S-6ST KO
mice was accompanied with increase in UA-GalNAc4S and UA2S-GalNAc4S
disaccharides and decrease in UA-GalNAc6S disaccharides (Fig. 6). It might be
possible that changes in disaccharides other than UA-GalNAc4S6S affect liver
fibrosis and repair significantly. However, this possibility seems to be unlikely
because interaction of various growth factors and cytokines with UA-GalNAc4S
was much lower than that with UA-GalNAc4S6S [45] and because both UA2S-
GalNAc4S and UA-GalNAc6S are only minor components of liver CS/DS.
In this report, we showed a possibility that disappearance of CS/DS-E resulted
from defect in GalNAc4S-6ST may be involved not only in the progression of liver
fibrosis but also in the recovery process in CCl4-treated mice. CS/DS-E was found
in macrophages derived from monocytes [40], and macrophages play important
roles not only in inflammation but also in tissue repair and/or regeneration [46]. It
remains to be determined whether CS/DS-E takes part in these processes through
affecting functions of macrophages. Comparison of differently activated macro-
phages obtained from wild type and GalNAc4S-6ST KO mice may provide some
clues about this issue.
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